Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
Open Access
- 1 September 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (9), 2460-2467
- https://doi.org/10.1158/1055-9965.epi-09-0058
Abstract
Genetic predisposition to prostate cancer includes multiple common variants with a low penetrance (single nucleotide polymorphisms) and rare variants with higher penetrance. The mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2 are associated with Lynch syndrome where colon and endometrial cancers are the predominant phenotypes. The purpose of our study was to investigate whether germ-line mutations in these genes may be associated with prostate cancer. One hundred and six male carriers or obligate carriers of MMR mutations were identified. Nine had contracted prostate cancer. Immunohistochemical analysis was done on tumor tissue from eight of the nine tumors. Observed incidence, cumulative risk at 60 and 70 years of age, age of onset, and Gleason score were compared with expected as assessed from population-based series. Absence of gene product from the mutated MMR gene was found in seven of eight tumors. Expected number of prostate cancers was 1.52 compared with 9 observed (P < 0.01). Mean age of onset of prostate cancer was 60.4 years compared with 66.6 expected (P = 0.006); the number of men with a Gleason score between 8 and 10 was significantly higher than expected (P < 0.00001). Kaplan-Meier analysis suggested that cumulative risk by 70 years in MMR mutation carriers may be 30% (SE, 0.088) compared with 8.0% in the general population. This is similar to the high risk associated with BRCA2 mutations. To our knowledge, this study is the first to indicate that the MMR genes may be among the rare genetic variants that confer a high risk of prostate cancer when mutated. (Cancer Epidemiol Biomarkers Prev 2009;18(9):2460–7)Keywords
This publication has 36 references indexed in Scilit:
- A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerBritish Journal of Cancer, 2009
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeBritish Journal of Cancer, 2008
- Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancerBritish Journal of Cancer, 2007
- Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsHuman Molecular Genetics, 2007
- Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)Journal of Medical Genetics, 2007
- Identification of germline MLH1 alterations in familial prostate cancerEuropean Journal Of Cancer, 2006
- The Tumor Spectrum in the Lynch SyndromeFamilial Cancer, 2005
- Where are the prostate cancer genes?—A summary of eight genome wide searchesThe Prostate, 2003
- Mutations in CHEK2 Associated with Prostate Cancer RiskAmerican Journal of Human Genetics, 2003
- THE MISMATCH REPAIR GENE hMSH2 IS MUTATED IN THE PROSTATE CANCER CELL LINE LNCaPJournal of Urology, 2000